FDA Alerts on Cardinal Health Correction for Recalled Infusion Sets in Presource Kits
The FDA has issued an alert regarding Cardinal Health's correction for specific Presource Kits that may contain previously recalled BD Alaris Pump Infusion Sets. These infusion sets can malfunction, leading to under- or over-infusion, which poses a risk of severe adverse events, especially for vulnerable patients. Healthcare facilities are advised to locate, quarantine, and label affected kits to ensure patient safety.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai